Selected research
Industry Research
Cobamamide API Industry Research Report 2026
Market perspective
The global Cobamamide API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cobamamide API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cobamamide API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cobamamide API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cobamamide API include HTBA, Interquim, Ningxia Kingvit Pharmaceutical, China Pharmaceutical Holding Group and Hebei Yuxing Bio-Engineering, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cobamamide API market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cobamamide API Market by Company
HTBA
Interquim
Ningxia Kingvit Pharmaceutical
China Pharmaceutical Holding Group
Hebei Yuxing Bio-Engineering
Cobamamide API Segment by Type
Purity≥98%
Purity<98%
Cobamamide API Segment by Application
Oral Formulation
Injectable Formulation
Cobamamide API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cobamamide API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cobamamide API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cobamamide API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cobamamide API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cobamamide API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cobamamide API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity≥98%
- Purity<98%
Applications
- Oral Formulation
- Injectable Formulation
Companies covered
- HTBA
- Interquim
- Ningxia Kingvit Pharmaceutical
- China Pharmaceutical Holding Group
- Hebei Yuxing Bio-Engineering
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cobamamide API Market Size (2021-2032)
- 2.2.2 Global Cobamamide API Sales (2021-2032)
- 2.2.3 Global Cobamamide API Market Average Price (2021-2032)
- 2.3 Cobamamide API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Purity≥98%
- 2.3.3 Purity<98%
- 2.4 Cobamamide API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Oral Formulation
- 2.4.3 Injectable Formulation
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cobamamide API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cobamamide API Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Cobamamide API Revenue of Manufacturers (2021-2026)
- 3.4 Global Cobamamide API Average Price by Manufacturers (2021-2026)
- 3.5 Global Cobamamide API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cobamamide API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cobamamide API, Product Type & Application
- 3.8 Global Manufacturers of Cobamamide API, Established Date
- 3.9 Global Cobamamide API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 HTBA
- 4.1.1 HTBA Company Information
- 4.1.2 HTBA Business Overview
- 4.1.3 HTBA Cobamamide API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 HTBA Cobamamide API Product Portfolio
- 4.1.5 HTBA Recent Developments
- 4.2 Interquim
- 4.2.1 Interquim Company Information
- 4.2.2 Interquim Business Overview
- 4.2.3 Interquim Cobamamide API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Interquim Cobamamide API Product Portfolio
- 4.2.5 Interquim Recent Developments
- 4.3 Ningxia Kingvit Pharmaceutical
- 4.3.1 Ningxia Kingvit Pharmaceutical Company Information
- 4.3.2 Ningxia Kingvit Pharmaceutical Business Overview
- 4.3.3 Ningxia Kingvit Pharmaceutical Cobamamide API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Ningxia Kingvit Pharmaceutical Cobamamide API Product Portfolio
- 4.3.5 Ningxia Kingvit Pharmaceutical Recent Developments
- 4.4 China Pharmaceutical Holding Group
- 4.4.1 China Pharmaceutical Holding Group Company Information
- 4.4.2 China Pharmaceutical Holding Group Business Overview
- 4.4.3 China Pharmaceutical Holding Group Cobamamide API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 China Pharmaceutical Holding Group Cobamamide API Product Portfolio
- 4.4.5 China Pharmaceutical Holding Group Recent Developments
- 4.5 Hebei Yuxing Bio-Engineering
- 4.5.1 Hebei Yuxing Bio-Engineering Company Information
- 4.5.2 Hebei Yuxing Bio-Engineering Business Overview
- 4.5.3 Hebei Yuxing Bio-Engineering Cobamamide API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hebei Yuxing Bio-Engineering Cobamamide API Product Portfolio
- 4.5.5 Hebei Yuxing Bio-Engineering Recent Developments
5 Global Cobamamide API Market Scenario by Region
- 5.1 Global Cobamamide API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cobamamide API Sales by Region: 2021-2032
- 5.2.1 Global Cobamamide API Sales by Region: 2021-2026
- 5.2.2 Global Cobamamide API Sales by Region: 2027-2032
- 5.3 Global Cobamamide API Revenue by Region: 2021-2032
- 5.3.1 Global Cobamamide API Revenue by Region: 2021-2026
- 5.3.2 Global Cobamamide API Revenue by Region: 2027-2032
- 5.4 North America Cobamamide API Market Facts & Figures by Country
- 5.4.1 North America Cobamamide API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cobamamide API Sales by Country (2021-2032)
- 5.4.3 North America Cobamamide API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Cobamamide API Market Facts & Figures by Country
- 5.5.1 Europe Cobamamide API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cobamamide API Sales by Country (2021-2032)
- 5.5.3 Europe Cobamamide API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Cobamamide API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cobamamide API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cobamamide API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cobamamide API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cobamamide API Market Facts & Figures by Country
- 5.7.1 South America Cobamamide API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cobamamide API Sales by Country (2021-2032)
- 5.7.3 South America Cobamamide API Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Cobamamide API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cobamamide API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cobamamide API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cobamamide API Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Cobamamide API Sales by Type (2021-2032)
- 6.1.1 Global Cobamamide API Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Cobamamide API Sales Market Share by Type (2021-2032)
- 6.2 Global Cobamamide API Revenue by Type (2021-2032)
- 6.2.1 Global Cobamamide API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cobamamide API Revenue Market Share by Type (2021-2032)
- 6.3 Global Cobamamide API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cobamamide API Sales by Application (2021-2032)
- 7.1.1 Global Cobamamide API Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Cobamamide API Sales Market Share by Application (2021-2032)
- 7.2 Global Cobamamide API Revenue by Application (2021-2032)
- 7.2.1 Global Cobamamide API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cobamamide API Revenue Market Share by Application (2021-2032)
- 7.3 Global Cobamamide API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cobamamide API Value Chain Analysis
- 8.1.1 Cobamamide API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cobamamide API Production Mode & Process
- 8.2 Cobamamide API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cobamamide API Distributors
- 8.2.3 Cobamamide API Customers
9 Global Cobamamide API Analyzing Market Dynamics
- 9.1 Cobamamide API Industry Trends
- 9.2 Cobamamide API Industry Drivers
- 9.3 Cobamamide API Industry Opportunities and Challenges
- 9.4 Cobamamide API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst